CureVac N.V. (CVAC) Stock creates opportunities due to its volume and complexity
SVB Securities raised the price target for the CureVac N.V. (NASDAQ:CVAC) stock to “an Outperform”. The rating was released on June 08, 2023, according to finviz. We previously noted in another research note published on January 19, 2023 by UBS that upgraded the stock from a Neutral to a Buy with a price target of […]
Trading CureVac N.V. (CVAC) Stock is a good strategy
SVB Securities raised the price target for the CureVac N.V. (NASDAQ:CVAC) stock to “an Outperform”. The rating was released on June 08, 2023, according to finviz. We previously noted in another research note published on January 19, 2023 by UBS that upgraded the stock from a Neutral to a Buy with a price target of […]
What are the chances of CureVac N.V. (CVAC) Stock turning the corner?
SVB Securities raised the price target for the CureVac N.V. (NASDAQ:CVAC) stock to “an Outperform”. The rating was released on June 08, 2023, according to finviz. We previously noted in another research note published on January 19, 2023 by UBS that upgraded the stock from a Neutral to a Buy with a price target of […]
CureVac N.V. (NASDAQ:CVAC) stock Market Value Reached at $644.77 million: What Happened?
SVB Securities raised the price target for the CureVac N.V. (NASDAQ:CVAC) stock to “an Outperform”. The rating was released on June 08, 2023, according to finviz. We previously noted in another research note published on January 19, 2023 by UBS that upgraded the stock from a Neutral to a Buy with a price target of […]
Why CureVac N.V. (NASDAQ:CVAC) Stock Decreased -6.67 percent in recent Trade?
SVB Securities raised the price target for the CureVac N.V. (NASDAQ:CVAC) stock to “an Outperform”. The rating was released on June 08, 2023, according to finviz. We previously noted in another research note published on January 19, 2023 by UBS that upgraded the stock from a Neutral to a Buy with a price target of […]
CureVac N.V. (CVAC) Stock Still Strong Despite Competition
SVB Securities raised the price target for the CureVac N.V. (NASDAQ:CVAC) stock to “an Outperform”. The rating was released on June 08, 2023, according to finviz. We previously noted in another research note published on January 19, 2023 by UBS that upgraded the stock from a Neutral to a Buy with a price target of […]
